Correction: Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study
Pediatr Res
.
2024 Mar;95(4):1159.
doi: 10.1038/s41390-023-02835-4.
Authors
Betzana Zambrano
#
1
,
James Peterson
2
,
Carmen Deseda
3
,
Katie Julien
4
,
Craig A Spiegel
5
,
Clifford Seyler
6
,
Michael Simon
7
,
Robert Hoki
8
,
Marc Anderson
9
,
Brad Brabec
10
,
Germán Áñez
#
11
,
Jiayuan Shi
12
,
Judy Pan
12
,
Audrey Hagenbach
13
,
Dalia Von Barbier
14
,
Kucku Varghese
15
,
Emilia Jordanov
11
,
Mandeep Singh Dhingra
16
Affiliations
1
Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay.
2
J. Lewis Research, Salt Lake City, UT, USA.
3
Caribbean Travel Medicine Clinic, San Juan, Puerto Rico.
4
J. Lewis Research Inc, South Jordan, UT, USA.
5
Craig A. Spiegel, MD Bridgeton, Bridgeton, MO, USA.
6
Pediatric Clinical Trials Tullahoma, Tullahoma, TN, USA.
7
Michael W. Simon, MD, PSC, Lexington, KY, USA.
8
Wee Care Pediatrics, Layton, UT, USA.
9
Tanner Clinic, Layton, UT, USA.
10
Midwest Children's Health Research Institute, Lincoln, NE, USA.
11
Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
12
Global Biostatistical Sciences, Sanofi, Swiftwater, PA, USA.
13
Sanofi, Marcy L'Étoile, France.
14
Sanofi, Swiftwater, PA, USA.
15
Global Clinical Immunology, Sanofi, Swiftwater, PA, USA.
16
Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. MandeepSingh.Dhingra@sanofi.com.
#
Contributed equally.
PMID:
37853068
PMCID:
PMC10920185
DOI:
10.1038/s41390-023-02835-4
No abstract available
Publication types
Published Erratum